Jul 28, 2022

Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants

Jul 11, 2022

Aethlon Medical Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment

Jun 28, 2022

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

Jun 21, 2022

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 28, 2022

May 17, 2022

/C O R R E C T I O N -- Aethlon Medical, Inc./

May 2, 2022

Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants

Mar 28, 2022

Aethlon Medical, Inc. Appoints Angela Rossetti to Board of Directors

Feb 14, 2022

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

Jan 31, 2022

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022

Nov 9, 2021

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update